OpportunityAnalyzer: Pulmonary Arterial Hypertension Report 2017 - Opportunity Analysis and Forecasts to 2026 - ResearchAndMarkets.com

Published: 1/02/2018
OpportunityAnalyzer: Pulmonary Arterial Hypertension Report 2017 - Opportunity Analysis and Forecasts to 2026 - ResearchAndMarkets.com
Source: WWW.BUSINESSWIRE.COM

DUBLIN--(BUSINESS WIRE)--The "OpportunityAnalyzer: Pulmonary Arterial Hypertension - Opportunity Analysis and Forecasts to 2026" drug pipelines has been added to ResearchAndMarkets.com's offering. Pulmonary arterial hypertension (PAH) market has generated much interest and investment from drug developers over the past several years, despite PAH being a rare disease. Current treatments include 1

Read more
Related news
Comment
FACEBOOK